|
LSN's Sourcing & Ranking Service (SRS) provides clients with an opportunity to quickly source, vet, rank and engage with partners that are licensing global technology assets.
|
|
Click to see investors that are a fit for your product and stage of development
|
|
Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you
|
|
Click here if you want to receive free, targeted early stage dealflow for your life science investment firm
|
|
|
 |
 |
 On April 10, more than 600 entrepreneurs and investors entered the exhibition hall at MaRS Discovery District in Toronto. They were greeted by 30 Innovation Challenge finalists across therapeutics, medical device, diagnostics, and healthcare IT sectors. The 30 companies, hand selected by LSN's scientific and commercial review team, competed directly on merits of innovation and commercial viability. We wish all our finalists the best in bringing their products forward toward commercialization, but there could only be 3 top prize winners.
|
|
| Lucy Parkinson, VP of Investor Research, Life Science Nation | Yasaman Soudagar, Founder, CEO, Neurescence | Dennis Ford, Founder & CEO, Life Science Nation | Ying Tam, Managing Director, Health Ventures, MaRS |
|
|
| Lucy Parkinson, VP of Investor Research, Life Science Nation | Steven ten Holder, Founder & COO, Acorn Biolabs | Drew Taylor, CEO, Acorn Biolabs | Dennis Ford, Founder & CEO, Life Science Nation | Ying Tam, Managing Director, Health Ventures, MaRS |
If you missed out on the opportunity to compete in the RESI on MaRS Innovation Challenge, we'd be happy to take your application for our upcoming Boston event on June 4th.
|
|
Life Science Nation (LSN), and the RESI Conference, now sets its sights on RESI Boston on June 4th, the day before the annual BIO Convention. This is the second year in a row LSN is holding a RESI conference during BIO week, which promises to bring more than 15,000 life science executives to Boston. RESI specializes in early-stage investor partnering, touting hundreds of qualified investment firms interested in meeting with innovative life science startups. No other conference has such a deeply-rooted focus on early-stage investment, complete with a robust data platform to connect only with those firms who are the right match.
Registration is now open at the Early Bird Rate. If you would like to learn more about RESI Boston and why it's a great choice for incorporating into your summer fundraising plans, don't hesitate to contact us.
|
|
Created & Produced by
|
 |
|
|
|
